Effects of Vitamin D in Patients With Breast Cancer
Status:
Completed
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
This protocol is a randomized, phase 2 "window of opportunity" trial assessing the biological
effects of short term oral vitamin D administration on breast cancer clinical and
translational markers in patients awaiting surgery at the Ottawa Hospital. It takes advantage
of the current wait times (2-8 weeks) for breast cancer surgery as a "window of opportunity"
to rapidly assess biological changes with vitamin D intake.
Phase:
Phase 2
Details
Lead Sponsor:
Ottawa Hospital Research Institute
Collaborator:
Canadian Breast Cancer Foundation
Treatments:
Cholecalciferol Ergocalciferols Vitamin D Vitamins